People with type 2 diabetes often struggle to manage their blood sugar and keep a healthy weight. A new analysis looked at real-world data to see how the medication tirzepatide works outside of controlled trials. This review combined information from 89,296 adults to get a clearer picture of what happens in everyday practice.
The study found that users taking tirzepatide saw their average blood sugar drop by 0.91 percent. On average, people lost 9.7 kilograms of weight. More than half of the users reached a target blood sugar level, and nearly half lost at least five percent of their starting weight.
However, this analysis relied on real-world studies which can have moderate to serious bias. This means the results support clinical trial findings but do not prove cause and effect. The review confirms that tirzepatide helps manage diabetes and weight in the real world, but readers should remember the limitations of observational data.